Evidence map›Paper›PMID 36680051›Full record

ArticleViruses2022

Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination.

Margret Paar, Faisal Aziz, Caren Sourij, Norbert J Tripolt, Harald Kojzar, Alexander Müller, Peter Pferschy, Anna Obermayer, Tamara Banfic, Bruno Di Geronimo Quintero and 11 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 1 institution in 1 country.

Margret PaarDivision of Medicinal Chemistry, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0001-5494-8890
Faisal AzizDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.
Caren SourijDivision of Cardiology, Medical University of Graz, 8010 Graz, Austria.
Norbert J TripoltDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.
Harald KojzarDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.
Alexander MüllerDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.
Peter PferschyDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.
Anna ObermayerDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-7663-0426
Tamara BanficDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.
Bruno Di Geronimo QuinteroDivision of Medicinal Chemistry, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.
Nandu GoswamiDivision of Physiology, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-6704-0723
Axel SchlagenhaufDepartment of Pediatrics and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, 8010 Graz, Austria.
Martin KöstenbergerDepartment of Pediatrics and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-1766-7859
Thomas BärnthalerDivision of Pharmacology, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-4988-3700
Thomas WagnerDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, 8010 Graz, Austria.
Andelko HrzenjakDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-8149-8191
Willibald WonischDivision of Medicinal Chemistry, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0001-7171-9539
Gilbert ReibneggerDivision of Medicinal Chemistry, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.
Reinhard B RaggamDivision of Angiology, Medical University of Graz, 8010 Graz, Austria.
Harald SourijDivision of Endocrinology and Diabetology, Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-3510-9594
Gerhard CvirnDivision of Medicinal Chemistry, Otto Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-1410-1844
Medical University of Graz · AT

Funding

Austrian Science Fund FWF KLI 1076
6 · The paper itself

Abstract

People with diabetes have an increased risk of experiencing adverse COVID-19 outcomes. COVID-19 vaccination is, therefore, highly recommended. However, people with diabetes have an inherently elevated risk of thrombotic events and the impact of the vaccination on the coagulation system in this patient population remains to be elucidated. The aim of this study was to investigate the impact of COVID-19 vaccination on the haemostatic system in people with type 1 or type 2 diabetes. We evaluated the effects of COVID-19 vaccination (BioNTech Pfizer, Moderna, AstraZeneca) on standard coagulation parameters, whole blood coagulation (Thrombelastometry), platelet function (impedance aggregation), and thrombin generation (calibrated automated thrombography) in people with type 1 diabetes mellitus (

Indexed as

COVID-19Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2HemostaticsCOVID-19 VaccinesHumansThrombinVaccinationCOVID-19 VaccinesHemostaticsThrombinCOVID-19platelet functionthrombelastometrythrombin generationtype 1 diabetestype 2 diabetes

Identifiers

PMID36680051
PMCPMC9867445
OpenAlexW4313466177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.